| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/13/2007 | WO2005021716A3 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders |
| 09/13/2007 | WO2000061614A8 Uncoupling proteins |
| 09/13/2007 | US20070214520 wound closure or coverage systems, comprising employing the recombinant spider silk protein; artificial cartilage, tendon materials, automotive parts or parts used in the aircraft construction, which comprise the protein |
| 09/13/2007 | US20070214519 Having gene encoding enzyme that can transfer fucose residue to reducing terminal of acetylglucosamine residue of glycoprotein sugar chain |
| 09/13/2007 | US20070214511 Transgenic Bird And Method Of Constructing The Same |
| 09/13/2007 | US20070213510 Compositions and methods comprising a ligand of ChemerinR |
| 09/13/2007 | US20070213389 Process and substances for the release of a growth-regulating factor from endothelial cells |
| 09/13/2007 | US20070213269 Zinc finger binding domains for tnn |
| 09/13/2007 | US20070213268 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis |
| 09/13/2007 | US20070213267 Peptides and Calcium Regulation in Mammalian Cells |
| 09/13/2007 | US20070213261 Asthma Preparation |
| 09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
| 09/13/2007 | US20070213255 Novel Hyaluronan-Binding Proteins and Encoding Genes |
| 09/13/2007 | US20070213253 Synuclein Mutant Having Aggregation-Inhibitory Activity |
| 09/13/2007 | US20070212769 Transfection, culturing; electrophoresis |
| 09/13/2007 | US20070212757 Expression System for the B Subunit of Cholera Toxin |
| 09/13/2007 | US20070212756 Methods for treating lentivirus infections |
| 09/13/2007 | US20070212755 Novel Sequence for Improving Expression of Nucleic Acid |
| 09/13/2007 | US20070212754 Selective detection of HCV NS2/3 autocleavage activity hence; identification of potential HCV inhibitor compounds |
| 09/13/2007 | US20070212753 Altered antibodies and their preparation |
| 09/13/2007 | US20070212752 Cell-free protein synthesis for controlling introduction of modification group into protein |
| 09/13/2007 | US20070212743 Assays for Determining Anticoagulant Cofactor Activity |
| 09/13/2007 | US20070212728 32263, a novel human biotin enzyme and uses thereof |
| 09/13/2007 | US20070212717 Method for Inhibiting Hepatitis C Virus Replication |
| 09/13/2007 | US20070212716 Nezara viridula Ecdysone Receptor |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212711 P1-34 Expression Units |
| 09/13/2007 | US20070212707 Cell cycle markers |
| 09/13/2007 | US20070212706 Novel alkaline proteases and detergents and cleaners comprising these novel alkaline proteases |
| 09/13/2007 | US20070212705 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity |
| 09/13/2007 | US20070212692 Generation Of Recombinant Genes In Prokaryotic Cells By Using Two Extrachromosomal Elements |
| 09/13/2007 | US20070212390 Protease-resistant forms of VEGF-D, method of making and method of use |
| 09/13/2007 | US20070212374 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus l1 proteins, and uses thereof |
| 09/13/2007 | US20070212369 Colon Specific Genes and Proteins |
| 09/13/2007 | US20070212365 recombinantly produced polypeptide; contacting a vascular cell with polypeptide for inhibiting angiogeneisis |
| 09/13/2007 | US20070212363 Immunoglobulins with Potent and Broad Antiviral Activity |
| 09/13/2007 | US20070212357 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy |
| 09/13/2007 | US20070212355 GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and Uses |
| 09/13/2007 | US20070212350 Rs7 antibodies |
| 09/13/2007 | US20070212349 antibodies and antibody fragments that specifically bind a CD4-inducible HIV gp120 epitope that is enhanced by binding a co-receptor for HIV, such as chemokine receptors, used for inhibiting HIV entry into cells and inhibiting replication of HIV in mammals |
| 09/13/2007 | US20070212347 Compositions and methods for treating polycystic kidney disease gene |
| 09/13/2007 | US20070212341 Method for Preparing Active Kinases Containing Ph Domains |
| 09/13/2007 | US20070212301 Monkey Immunoglobulin Sequences |
| 09/13/2007 | US20070212299 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 09/13/2007 | DE10037270B4 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
| 09/13/2007 | CA2644588A1 Truncated proteins as cancer markers |
| 09/13/2007 | CA2644170A1 Humanized anti-cd20 monoclonal antibody |
| 09/12/2007 | EP1832654A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 09/12/2007 | EP1832567A2 Evolving new molecular function |
| 09/12/2007 | EP1832297A1 Anticoagulant agents useful in treatment of thrombosis |
| 09/12/2007 | EP1831389A1 Method for biotransformation of the clyclosporin compound isa247 |
| 09/12/2007 | EP1831385A2 Enzymes for starch processing |
| 09/12/2007 | EP1831384A2 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 09/12/2007 | EP1831373A2 Recombinant production of serum albumin |
| 09/12/2007 | EP1758614A4 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof |
| 09/12/2007 | EP1481053B1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1391510B1 Method of constructing host and process for producing foreign protein |
| 09/12/2007 | EP1373570B1 Improved in vitro synthesis system |
| 09/12/2007 | EP1299541B1 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/12/2007 | EP0970127B1 Induction of immunological tolerance to a therapeutic antibody using variants of the said therapeutic antibody |
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | CN101035895A 酵母启动子 Yeast promoters |
| 09/12/2007 | CN101035807A Diagnosis and treatment of SIGLEC-6 associated diseases |
| 09/12/2007 | CN101033481A Preparing process of extracting bone collagen from pig, cattle and sheep bone |
| 09/12/2007 | CN100336912C Method for preparing recombined human atrial natriuretic peptide rhANP by using ferment in high density |
| 09/12/2007 | CN100336911C Method for separating and purifying ice nucleus active protein from ice nucleus active bacteria |
| 09/12/2007 | CN100336908C Production of recombinant anthrax protective antigen and its special expression plasmid |
| 09/12/2007 | CN100336907C Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof |
| 09/11/2007 | US7268275 tcdB2 protein from Photorhabdus luminescens W-14 |
| 09/11/2007 | US7268272 Genetic control of plant growth and development |
| 09/11/2007 | US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 09/11/2007 | US7268222 For use in therapeutic, diagnostic, and pharmacogenomic applications |
| 09/11/2007 | US7268221 Alpha(1,6)-linked glucose oligosaccharide hydrolyzing enzyme polynucleotides and polypeptides and methods of use thereof |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268217 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative, nervous system and tumor disorders |
| 09/11/2007 | US7268215 Bioluminescent protein for use as tool in detection of monovalent cations derived from symplectoteuthis oualaniensis |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268116 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 09/11/2007 | US7268114 Protein and process for preparing the same |
| 09/11/2007 | US7267983 peptides which include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins formulated in culture medium to produce the desired effect on cultured cells; useful in concatemer-based recombinant expression methods |
| 09/11/2007 | US7267976 Suitable for use in the manufacture of microbial oils enriched in omega fatty acids in oleaginous yeast (e.g., Yarrowia lipolytica) |
| 09/11/2007 | US7267969 Thermostable omega-transaminases |
| 09/11/2007 | US7267965 Providing at least one Stabilizing Anti-Repression sequence to a nucleic acid encoding a protein enhances production (yield) of the protein by a host cell increases the proportion of host cells with acceptable expression levels, and/or increases stability of a gene expression level. |
| 09/11/2007 | US7267957 Incorporation of highly specific receptors into an amplification mechanism, including antibody-embedded liquid crystalline materials, for the rapid and automatic detection of ligands, particularly pathogens and/or their toxins; can be used for early diagnoses |
| 09/11/2007 | US7267944 Methods and compositions for combinatorial-based discovery of new multimeric molecules |
| 09/11/2007 | US7267941 A viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity/immunogenicity, improve pharmacokinetics/bioavailability; envelope viruses |
| 09/11/2007 | CA2269111C Genes encoding plant transcription factors |
| 09/11/2007 | CA2196097C Secreted viral proteins useful for vaccines and diagnostics |
| 09/11/2007 | CA2172963C Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 09/11/2007 | CA2151381C Recombinant dog gastric lipase and pharmaceutical compositions |
| 09/07/2007 | WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule |
| 09/07/2007 | WO2007100083A1 Modified antibody with enhanced bioactivity |
| 09/07/2007 | WO2007100075A1 Yeast capable of producing selenomethionine-containing protein |
| 09/07/2007 | WO2007099988A1 α-1,6-FUCOSYLTRANSFERASE MUTANT AND USE THEREOF |
| 09/07/2007 | WO2007099934A1 Aliphatic amino acid labeled with stable isotope, method of inserting the same in target protein, and method of nmr conformation analysis of protein |
| 09/07/2007 | WO2007099921A1 PEPTIDE BINGING TO PILRα, POLYNUCLEOTIDE ENCODING THE SAME AND APPLICATION THEREOF |
| 09/07/2007 | WO2007099854A1 METHOD FOR SYNTHESIS OF SUPPRESSOR tRNA, DNA CONSTRUCT, AND PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE DNA CONSTRUCT |
| 09/07/2007 | WO2007099776A1 Koji mold strain highly producing foreign protein |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |